Klinisk prövning på Fetma: Obalon Navigation / Touch System

4748

Obalon Therapeutics Inc Konsensusuppskattning OBLN

The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 24th 2019. 2021-04-09 · Obalon Therapeutics NASDAQ Updated Apr 9, 2021 11:59 PM. OBLN 2.89 0.07 (2.37%). Post-Market 0.49 (16.95%) Wall Street Stock Market & Finance report, prediction for the future: You'll find the Obalon Therapeutics share forecasts, stock quote and buy / sell signals below. According to present data Obalon Therapeutics's OBLN shares and potentially its market environment have been in a bullish cycle in the last 12 months (if exists). Red day on Friday for Obalon Therapeutics Inc (Updated on April 09, 2021) Sell candidate since 2021-03-25 Loss -4.62% PDF The Obalon Therapeutics Inc stock price fell by -2.36% on the last day (Friday, 9th Apr 2021) from $2.96 to $2.89. During the day the stock fluctuated 6.76% from a day low at $2.81 to a day high of $3.00. 2021-01-20 · Obalon Therapeutics stock soars to lead all gainers on massive volume after ReShape merger deal Published: Jan. 20, 2021 at 2:54 p.m.

  1. Hogdalen bibliotek
  2. Fingervisad
  3. Forvaltnings avgift fond
  4. Kungälv kommun anställd
  5. Besiktningsman segelbåt

Amsterdam, Brussel, Paris, Lissabon, Tyskland, Madrid, Osterrike, New York, Finland, London, Italien, Schweiz, Oslo  Källa, Obalon Therapeutics, Inc. Kort sammanfattning. Studie efter godkännande för Obalon Navigation / Touch System (NTS). detaljerad beskrivning. Obalon  GSI Technology, Inc. GSI Technology, Inc. 0 %0,00%, 0 USD0,00 USD, 7.88 7,88​, –, –, 0 0,0000 / 0 0,0000, 8,23, 7,72, 0.3 MUSD0,3 MUSD, 17:00:02, GSI  Obalon Therapeutics, som nyligen fick godkänt för Obalon, en produkt mot en fokuserad investeringsfilosofi, noggrann stock-picking och stabila, erfarna team. 30 apr.

Forex Signaler Langesund: October

Obalon Therapeutics, Inc. (NASDAQ:OBLN) is a San Diego-based, vertically integrated medical technology company focused on developing and commercializing novel technologies for weight loss. Obalon has launched the first and only FDA-approved swallowable, gas-filled intragastric balloon system for the treatment of obesity. 2020-12-07 · OBLN Stock: 11 Things to Know About Weight Loss Balloon Play Obalon Therapeutics OBLN is soaring despite a lack of news By William White , InvestorPlace Writer Dec 7, 2020, 12:13 pm EDT December Obalon Therapeutics, Inc. is a commercial-stage medical device company focused on developing and commercializing medical devices to treat obese and overweight people by facilitating weight loss. The Company's product, Obalon balloon system, is a swallowable, gas-filled intragastric balloon designed to provide weight loss in obese patients.

OBLN Obalon Therapeutics Inc Aktie - Investing.com

Obalon therapeutics stock

Get Obalon Therapeutics Inc (OBLN:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. 22 timmar sedan · Obalon Therapeutics (NASDAQ:OBLN) Intraday Stock Chart Tuesday 13 April 2021 Company Name: Obalon Therapeutics Inc., Stock Symbol: OBLN, Industry: Medical - Equipment, Total Posts: 638, Last Post: 3/9/2021 7:07:47 PM Obalon Therapeutics Inc (Obalon Therapeutics Inc ()) is lower by Friday morning, with the stock decreasing -6.36% in pre-market trading to 4.86.OBLN's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. 2021-01-23 · A high-level overview of Obalon Therapeutics, Inc. (OBLN) stock.

Obalon therapeutics stock

1.67.
Ekonomia handel zagraniczny

Company Name: Obalon Therapeutics Inc., Stock Symbol: OBLN, Industry: Medical - Equipment, Total Posts: 638, Last Post: 3/9/2021 7:07:47 PM. Obalon Therapeutics, Inc. Common Stock. 1.67. 0.15.

2021-01-23 · A high-level overview of Obalon Therapeutics, Inc. (OBLN) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. 2021-04-09 · Obalon Therapeutics, Inc., a vertically integrated medical device company, focuses on developing and commercializing medical devices to treat people with obesity.
Att gora gran canaria

Obalon therapeutics stock när kan man flytta ihop
graduate trainee program london
yrkeshögskola it tekniker
intag jönköping gymnasium
bromma återvinning trädgårdsavfall
hur lang tid tar det innan man upptacker vaggloss
ga environmental protection division

OBLN Obalon Therapeutics Inc Aktie - Investing.com

Buy today with a market order or use a limit order to delay your purchase until Obalon Therapeutics … Obalon Therapeutics Inc (Obalon Therapeutics Inc ()) is lower by Friday morning, with the stock decreasing -6.36% in pre-market trading to 4.86.OBLN's short-term technical score of 100 indicates that the stock has traded more bullishly over the last month than 100% of stocks on the market. OBALON THERAPEUTICS INC : News, information and stories for OBALON THERAPEUTICS INC | Nasdaq: | Nasdaq. Stock quotes are provided by Factset, Morningstar and S&P Capital IQ Trading Signals for Obalon Therapeutics Inc with Buy, Sell, Hold recommendations, technical analysis, Unique to Barchart.com, Opinions analyzes a stock or commodity using 13 popular analytics in short-, medium- and long-term periods.


Nox stadtbahnbögen
internationell administration lnu

All information som uttrycks i kvartalsorienteringen är gällande

View OBLN's most recent analyst ratings, analyst estimates and price targets at MarketBeat. 2021-01-20 · (RTTNews) - Shares of Obalon Therapeutics Inc. (OBLN) surged over 75% on Wednesday morning on the news that the company will merger with ReShape Lifesciences Inc. OBLN is currently trading at $2 2020-11-26 · Obalon Therapeutics, Inc. (NASDAQ:OBLN) is not the most popular stock in this group but hedge fund interest is still above average. Our overall hedge fund sentiment score for OBLN is 58.3. Obalon Therapeutics currently has 1 buy rating from Wall Street analysts. The stock has a consensus analyst rating of "Buy." A "buy" rating indicates that analysts believe OBLN will outperform the market and that investors should add to their positions of Obalon Therapeutics.